… reduced considerably if patients are monitored by molecular … , or competitive reverse
transcriptase polymerase chain reaction (… trial of interferon-alpha n 1 for chronic myeloid …

… and lower progression rates than interferon-alpha. However, … (FISH) and qualitative
polymerase chain reaction (PCR) have … The level of BCR-ABL measured by competitive Q-PCR is …

… be efficient in monitoring the percentage of Ph cells in patients … survival in chronic myelogenous
leukemia after cyto genetic … therapy by competitive polymerase chain reaction. Blood 87: …

… of individual patients to treatment or to evaluate the efficacy of a particular … in chronic
myelogenous leukemia patients on interferon-α therapy by competitive polymerase chain reaction. …

… polymerase chain reaction (RT-PCR) in the follow-up of CML … and to monitor the
response.27,28 However, the competitive … with high-quality performance characteristics will …

… their resistance to interferon-alpha or tyrosine kinase inhibitors. … in liquid culture or plating
efficiency in semisolid culture medium (… monitoring of residual disease in chronic myelogenous …

… ) a shift from using qualitative polymerase chain reaction (PCR) … Competitive polymerase
chain reaction to estimate the … after interferon-alpha therapy for chronic myelogenous leukemia: …

… was to evaluate the efficacy of a treatment protocol and to … patients were pretreated with
busulfan or interferon-alpha, … A hypothetical mechanism could be competition with IM for a …

… Patients should be monitored closely with cytogenetic and possibly other analyses such as
fluorescent in situ hybridisation (FISH) and polymerase chain reaction (… Although the efficacy …

… real-time quantitative polymerase chain reaction (RQ-PCR) … , whose efficacy as second-line
therapy in patients with imatinib-… of any products discussed in this article or their competitors. …